forms DNA-binding estrogen receptors human breast cancer likelihood breast cancer therapy tumor content immunoreactive ligand-binding estrogen receptor ER failure many ER-positive breast cancers therapy gel-shift ability tumor ER cognate estrogen response element ERE Analysis primary breast cancers tumors abundant immunoreactive ER DNA ER many ER-positive tumors fraction DNA ER low truncated receptor forms Western analysis kD homodimers kD ER heterodimers use protease inhibitors tumor extraction demonstration nuclear-localizing ER ERE-binding COUP upstream promoter protein tumors truncated forms ER likely present vivo presence intact DNA binding ER tumor content immunoreactive sex steroid receptors ER PR standard predictors tumor responsiveness loss truncation DNA ER important prognostic parameter accounting forms clinical resistance therapy 